NCT02091999 2024-11-01
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Astellas Pharma Inc
Phase 1 Completed
Clinical Trials
1 trialsMetastatic Urothelial Cancer and Other Malignant Solid Tumors × enfortumab vedotin × Other solid neoplasm × Clear all